Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Cancer Policy ; 27: 100256, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-35559933

RESUMO

BACKGROUND: Half of the UK population will get cancer during their lifetime, with the current survival rate at 50 %. Behavioural factors such as obesity contribute to two-fifths of the UK's most common cancers. Food 'pricing' and 'place and promotion' policies aim to avert this risk by reducing the rate of obesity in the UK. METHODS: A cross-sectional survey collected data on the acceptance of obesity-related pricing and place and promotion policies from 3293 UK adults in 2016. Cross-tabulations and chi-squared tests were performed to investigate the support for these policies in the four UK countries and different socioeconomic groups. RESULTS: Only two-fifths of respondents supported all policies. Food place and promotion policies were better supported by the public than taxation, with over 70 % support for the promotion of healthy foods as opposed to 40 % support for 'fat tax'. The most deprived social groups were least supportive of all policies. There was not a noticeable difference in policy support between the four UK countries. CONCLUSION: The support for obesity policies is low, most notably amongst lower socioeconomic groups and for policies involving a price increase, across the UK. POLICY SUMMARY: Obesity prevention policies could reduce the rate of related cancers, but their success requires public support and acceptance. Increasing tax on unhealthy foods is less well supported in the UK population than policies which affect the in-store placement and promotion of these products. Lower levels of support for all these policies among low-income groups, among whom obesity and cancer rates are highest, indicate a particular need for strategies to increase policy support in these groups.


Assuntos
Neoplasias , Obesidade , Estudos Transversais , Humanos , Obesidade/epidemiologia , Políticas , Reino Unido/epidemiologia
2.
Immun Inflamm Dis ; 9(4): 1648-1655, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-34438471

RESUMO

INTRODUCTION: This study aims to investigate in-hоsрitаl mоrtаlity in severe асute resрirаtоry syndrоme соrоnаvirus 2 Ñ€Ð°tients strаtified by serum ferritin levels. METHODS: Patients were stratified based on ferritin levels (ferritin levels ≤ 1000 or >1000). RESULTS: Approximately 89% (118) of the patients with ferritin levels > 1000 had pneumonia, and 51% (67) had hypertension. Fever (97, 73.5%) and shortness of breath (80, 61%) were two major symptoms among the patients in this group. Logistic regression analysis indicated that ferritin level (odds ratio [OR] = 0.36, 95% confidence interval [CI] = 0.21-0.62; p < .001), male sex (OR = 2.63, 95% CI = 1.43-5.06; p = .003), hypertension (OR = 4.16, 95% CI = 2.42-7.36; p < .001) and pneumonia (OR = 8.48, 95% CI = 3.02-35.45; p < .001) had significance in predicting in-hospital mortality. Additionally, the Cox proportional hazards analysis and Kaplan-Meier survival probability plot showed a higher mortality rate among patients with ferritin levels > 1000. CONCLUSION: In this study, higher levels of serum ferritin were found to be an independent predictor of in-hоsрitаl mоrtаlity.


Assuntos
COVID-19 , Pneumonia , Ferritinas , Humanos , Masculino , SARS-CoV-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA